2 Occam Court
Surrey Research Park
Guildford, Surrey
GU2 7QB
United Kingdom
Tel: +44 1483 595 000
Fax: +44 1483 595 001
4th Floor, Pembroke Building
Kensington Village
Avonmore Road
London, W14 8DG
United Kingdom
Tel: +44 207 565 8620
Fax: +44 207 565 8700
18 Rue Pasquier,
Paris, 75008
France
Tel: +33 01 78 41 44 46
1301 Marina Village Parkway
Suite 320,
Alameda, CA 94501
Tel: +1 510 814 4900
Fax: +1 510 814 4910
750 US Highway 202,
Suite 200,
Bridgewater, NJ 08807
Tel: +1 908 429 2900
Fax: +1 908 429 2901
25 Burlington Mall Road
1st Floor, Suite #107
Burlington, MA 01803
Tel: +1 781 272 3355
Fax: +1 781 272 3377
8770 W. Bryn Mawr,
Suite 1300,
Chicago, IL 60631
Tel: +1 773 867 2958
Shibuya Mark City W22F
1-12-1 Dogenzaka Shibuya-ku Tokyo
150-0043 Japan
Tel: +81 3 4360 5344
info-japan@idbs.com
Tel: +91-990-0064-922
+91-080-2587-0336
Room 207, Block A, Innovation Building
NO.333 Cailun Road, Zhangjiang High Tech. Park
Shanghai 201203
China
Tel: +86-21-6468-5535/6469-1770
Fax: +86-21-6468-5366
Conor Higgins
PO box 9079
Brighton
Melbourne
Vic 3186
Conor Higgins - chiggins@idbs.com
Tel: +61 410 708 052
Guildford, UK, and Burlington, Mass., February 22, 2011 - IDBS, a global provider of innovative enterprise data management, analytics and modeling solutions, today announced it will speak at Cambridge Healthtech Institute’s (CHI’s) annual Molecular Medicine Tri-Conference to be held February 23-25 in San Francisco.
The Tri-Conference event brings together leading scientists and executives from multiple therapeutic and diagnostic aspects of the industry to discuss cutting-edge research, trends, and analysis. Dr. Paul Denny-Gouldson, Vice President of Translational Research at IDBS will present a session entitled “Enterprise Translational Medicine: It’s a kind of magic,” as part of the Translational Science track in the conference’s Discovery and Development channel.
The convergence of life science research and medicine is leading to more personalized healthcare. Organizations need to implement advanced clinical research information systems (ACRIS) to combine clinical, molecular and imaging data to support translational research. ACRIS architectures typically have a research data repository (RDR) that is separate from medical record systems and is designed to answer scientific questions and assess patient outcomes. Collaborative web-based access to RDRs enable clinicians and researchers to browse clinical data and easily create patient cohorts. Critically, sample, molecular and research results also stored in the RDR can be used to stratify the patient cohorts.
Dr. Denny-Gouldson’s presentation will detail key lessons learned in designing and developing ACRIS-type systems for oncology, cardiovascular and neuroscience disease areas; it will also look at technical challenges of clinical data ETL and terminology mapping, pseudonymization, coping with large data sets such as Next Gen Sequencing (NGS) and cloud based deployment.
IDBS customer, Daniel Ingber, Senior Manager, Research Information Systems at MedImmune, will also be speaking on “Building a Translational Biomarker Data Mining and Data Warehouse Platform: Considerations”. Mr. Ingber will discuss how to build and manage a system with a flexible data model which supports a scalable, industrial-strength scientific data pipeline, leading to a better understanding of drug action, an improved ability to understand physiological responses, and better overview of inter-relationships between research and clinical data.
The 2011 Molecular Medicine Tri-Conference will be held at the Moscone North Convention Center in San Francisco, February 23-25, 2011. Mr. Ingber and Dr. Denny-Gouldson will present on Wednesday, February 23, at 3:20 and 3:50 pm, respectively. For conference information or to register, visit https://chidb.com/register/2011/mmtc/reg.asp.
IDBS is a global provider of innovative enterprise data management, analytics and modeling solutions. The company’s uniquely sophisticated platform technologies are used by more than 200 pharmaceutical companies, major healthcare providers, global leaders in academic study, and high tech companies to increase efficiency, reduce costs and improve the productivity of industrial R&D and clinical research. IDBS is clearly differentiated by its unique combination of award-winning enterprise technologies and domain knowledge in R&D.
IDBS’ solutions help scientists, hospitals and R&D businesses produce the world’s newest therapeutics, diagnostics and personalized treatments, high-tech materials and consumer products, faster, cleaner engines and fuels, breakthroughs in productive agriculture, healthy, safer food products, and high tech materials and products.
Founded in 1989 and privately held, IDBS is headquartered in Guildford, UK with a direct sales and support presence worldwide. IDBS is a 2010 Profit Track 100 company and the recipient of multiple awards including the Frost and Sullivan 'Enabling Technology' Award in R&D data management for 2010 and Queen's Award for International Trade 2011. For regular updates follow us on Twitter @IDBSsoftware
Danielle Guinebertiere, IDBS Communications Director
Tel: +1 908 429 2933
Email: dguinebertiere@idbs.com
" IDBS products provide a complete view on our data, reducing experiment duplication, sharing data across the organization and freeing scientists from report creation, giving them back vital research hours. "
Hector Sanchez
Senior Director R&D Informatics, UCB